Target Aortic Stenosis: A National Initiative to Improve Quality of Care and Outcomes for Patients with Aortic Stenosis

Brian R. Lindman*, Gregg C. Fonarow, Gary Myers, Heather M. Alger, Christine Rutan, Katie Troll, Angeline Aringo, Melanie Shahriary, Mariell Jessup, Suzanne V. Arnold, Pinak B. Shah, Wilson Y. Szeto, Clyde W. Yancy, Catherine M. Otto

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations
Original languageEnglish (US)
Pages (from-to)E009712
JournalCirculation: Cardiovascular Quality and Outcomes
Volume16
Issue number6
DOIs
StatePublished - Jun 1 2023

Funding

Dr Lindman is supported by R01AG073633 from the National Institutes of Health and has consulted for and received research grants from Edwards Lifesciences. Dr Fonarow reports consulting with Abbott, Amgen, AstraZeneca, Bayer, Cytokinetics, Eli Lilly, Edwards Lifesciences, Janssen, Medtronic, Merck, and Novartis. Dr Szeto has served on the advisory board and as an investigator and speaker for Edwards Lifesciences and Medtronic. Dr Alger is affiliated with Anumana, Inc, and is an employee of Nference, Inc; her contributions to the present work were completed as an employee of the American Heart Association. The other authors report no conflicts.

Keywords

  • aortic valve replacement
  • aortic valve stenosis
  • cardiology
  • echocardiography
  • ethnicity
  • patient acuity
  • quality of health care

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this